You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 365 Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy for advanced ovarian, fallopian tube and primary peritoneal cancer patients

Article metrics

Article menu

Download PDFPDF

Poster
IGCS20_1391
365 Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy for advanced ovarian, fallopian tube and primary peritoneal cancer patients
Free

 

Online download statistics by month:

Online download statistics by month: November 2020 to December 2024

AbstractFullPdf
Nov 20202405
Dec 20201803
Jan 20211204
Feb 20211401
Mar 20211402
Apr 20212206
May 2021301
Jun 2021002
Jul 2021001
Aug 2021005
Sep 2021001
Oct 20211016
Nov 20214016
Dec 2021602
Jan 2022400
Feb 2022800
Mar 2022201
May 20221607
Jun 2022704
Jul 20223001
Aug 20221006
Sep 20221205
Oct 2022801
Nov 2022400
Dec 2022802
Jan 2023803
Feb 20231100
Mar 20231501
Apr 2023200
May 2023400
Jun 2023201
Jul 2023603
Aug 2023602
Sep 2023201
Oct 2023807
Nov 20231001
Dec 20232901
Jan 2024200
Feb 2024603
Mar 20248028
Apr 2024909
May 2024402
Jun 20241001
Jul 2024200
Aug 20241005
Sep 20241804
Oct 20241102
Nov 20241402
Dec 2024200
Total4260168